Netherlands· NL-c20273899a38

Cabergoline Renata, tabletten 0,5 mg

A cabergoline product containing cabergoline, registered in Netherlands by Renata Pharmaceuticals (Ireland) Limited. The same ATC class is registered in 13 of our 19 countries.

ATC G02CB03

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about cabergolineAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Cabergoline is registered in 13 of 19 countries.

Countries holding a registration under ATC G02CB03 (cabergoline), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
8 of them publish a price we can compare per daily dose

Search cabergoline products by name

Cabergoline · ATC G02CB03

13 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Switzerlandprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of cabergoline costs, country by country.

Normalised to the WHO defined daily dose (0.5 mg), the median price runs from $3.40 in France to $11.81 in Switzerland — a ×3.5 gap.

3 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Cabergoline · price per daily dose (0.5 mg)

USD · FX 28 Sept 2026

CH Switzerland$11.81
IT Italy$4.08
FR France$3.40

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: CABERGOLINE
Manufacturer: Renata Pharmaceuticals (Ireland) Limited
Country: Netherlands (NL)
ATC code: G02CB03
ATC class: Cabergoline
Defined daily dose: 0.5 mg, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
131086

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

65 interactions on record for cabergoline.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check cabergoline against other medicines How interaction checks work

Cabergoline · interactions on record

65 records

3 severe
17 moderate
45 info

Most severe, free to view

LorcaserinA08AA11severe
ErythromycinJ01FA01severe
ClarithromycinJ01FA09severe
MetoclopramideA03FA01moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cabergoline in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cabergoline products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

Austria · Cabaseril, Dostinex
Belgium · Cabergoline Teva, Dostinex
Bulgaria · Достинекс
Cyprus · Dostinex
Czechia · Dostinex
Germany · Cabaseril, Cabergoletten
Denmark · Cabenex, Cabergolin Teva
Spain · Cabergolina Teva, Dostinex
Finland · Cabaser, Dostinex
France · Cabergoline Arrow, Cabergoline Biogaran
United Kingdom (Northern Ireland) · Cabaser, Cabergoline Aspire Pharma
Greece · Dostinex
Croatia · Dostinex
Ireland · Cabaser, Cabergoline Renata Pharmaceuticals (Ireland)
Iceland · Dostinex
Italy · Cabaser, Cabergolina Aurobindo
Luxembourg · Cabergoline Teva, Dostinex
Latvia · Dostinex
Malta · Cabergoline Aurobindo, Cabergoline Doc
Norway · Cabergoline Renata Pharmaceuticals (Ireland), Dostinex
Poland · Dostinex
Portugal · Cabergolina Generis, Cabergoline 0.5 Mg Tablets
Romania · Dostinex
Sweden · Cabenex, Cabergoline Ratiopharm
Slovakia · Cabest

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/f18d394b-039c-400a-a61e-d59299a2c5cd
GET /v1/drugs/f18d394b-039c-400a-a61e-d59299a2c5cd?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h131086_smpc_en.pdf",
  "strength": null,
  "atc_label": "Cabergoline",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg131086",
  "excipients": [
    "LACTOSE 0-WATER",
    "LEUCINE, (L-) (E 641)",
    "MAGNESIUMSTEARAAT (E 470b)"
  ],
  "substances": [
    "CABERGOLINE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h131086_piluk.pdf",
  "authorised_at": "2024/09/30",
  "procedure_number": "IE/H/1256/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "131086",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about cabergoline.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console